Kalgene Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Kalgene Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10919
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kalgene Pharmaceuticals Inc (Kalgene Pharmaceuticals) is a pre-clinical stage biotechnology company focused on the development of novel fusion protein therapeutic’s for the treatment of neurodegenerative diseases. Its lead product candidate KAL-ABP, targets toxic amyloid beta oligomers that cross the blood-brain barrier by improving the cognition and neuronal connectivity that slow down the progression of Alzheimer’s disease. The company works in partnership with The National Research Council of Canada, McGill University, Weston Brain Institute, CQDM, Brain Canada and Ontario Brain Institute. Kalgene Pharmaceuticals is headquartered in Montreal, Quebec, Canada.

Kalgene Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kalgene Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kalgene Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kalgene Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kalgene Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kalgene Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Kalgene Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kalgene Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Kalgene Pharma Raises Funds through Series A Financing 11
Partnerships 12
Kalgene Pharma Enters into Agreement with National Research Council of Canada 12
Kalgene Pharma Enters into Co-Development Agreement with Sunnybrook Research Institute, CIMTEC and OCBN 13
Licensing Agreements 14
Kalgene Pharma Enters into Licensing Agreement with National Research Council of Canada 14
Kalgene Pharmaceuticals Inc – Key Competitors 15
Kalgene Pharmaceuticals Inc – Key Employees 16
Kalgene Pharmaceuticals Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Kalgene Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Kalgene Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kalgene Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kalgene Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kalgene Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Kalgene Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Kalgene Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kalgene Pharma Raises Funds through Series A Financing 11
Kalgene Pharma Enters into Agreement with National Research Council of Canada 12
Kalgene Pharma Enters into Co-Development Agreement with Sunnybrook Research Institute, CIMTEC and OCBN 13
Kalgene Pharma Enters into Licensing Agreement with National Research Council of Canada 14
Kalgene Pharmaceuticals Inc, Key Competitors 15
Kalgene Pharmaceuticals Inc, Key Employees 16

List of Figures
Kalgene Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Kalgene Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Kalgene Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Kalgene Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Kalgene Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kalgene Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Kalgene Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kalgene Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kalgene Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Kalgene Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dongfang Electric Corporation Ltd (1072):企業の財務・戦略的SWOT分析
    Dongfang Electric Corporation Ltd (1072) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • 3i Infotech Ltd (3IINFOTECH):企業の財務・戦略的SWOT分析
    3i Infotech Ltd (3IINFOTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Nanolek-製薬・医療分野:企業M&A・提携分析
    Summary Nanolek specializes in the production of import-substituting and novel pharmaceuticals. The company’s product portfolio includes vaccines; drugs for treatment of leukemias, brain cancer, breast cancer, stomach and ovarian cancer, colorectal cancer, HIV infection and other diseases. Nanolek a …
  • The Economist Group Ltd:企業の戦略的SWOT分析
    The Economist Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Swire Pacific Ltd:戦略・SWOT・企業財務分析
    Swire Pacific Ltd - Strategy, SWOT and Corporate Finance Report Summary Swire Pacific Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Spitfire Oil Ltd (SRO):企業の財務・戦略的SWOT分析
    Summary Spitfire Oil Ltd (Spitfire) is an oil and gas company that produces and markets liquid hydrocarbons. The company's liquid hydrocarbons include fuel oil and distillate from the Salmon Gums Lignite Deposit. Its Salmon Gums Lignite deposit is located in Western Australia near Salmon Gums and co …
  • Gulf Investment Corporation:企業の戦略的SWOT分析
    Gulf Investment Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Altin Yunus Cesme Turistik Tesisler A.S.
    Altin Yunus Cesme Turistik Tesisler A.S. - Strategy, SWOT and Corporate Finance Report Summary Altin Yunus Cesme Turistik Tesisler A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Emlin Cosmetics :企業の戦略・SWOT・財務情報
    Emlin Cosmetics - Strategy, SWOT and Corporate Finance Report Summary Emlin Cosmetics - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Noni B Ltd (NBL):企業の財務・戦略的SWOT分析
    Noni B Ltd (NBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Molinos Rio de la Plata SA (MOLI3):企業の財務・戦略的SWOT分析
    Molinos Rio de la Plata SA (MOLI3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Grunenthal GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Grunenthal GmbH (Grunenthal) is a research-oriented pharmaceutical company. It researches, develops, produces and markets products for the treatment of pain and innovative formulations of established active substances. The company provides new chemical entities including opioids for moderate …
  • A. O. Smith Corporation (AOS):企業の財務・戦略的SWOT分析
    A. O. Smith Corporation (AOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Saipem SpA:企業の戦略・SWOT・財務情報
    Saipem SpA - Strategy, SWOT and Corporate Finance Report Summary Saipem SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Magnit:企業の戦略・SWOT・財務情報
    Magnit - Strategy, SWOT and Corporate Finance Report Summary Magnit - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Capitol Federal Financial Inc:企業の戦略・SWOT・財務分析
    Capitol Federal Financial Inc - Strategy, SWOT and Corporate Finance Report Summary Capitol Federal Financial Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Herman Miller Inc (MLHR):企業の財務・戦略的SWOT分析
    Herman Miller Inc (MLHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Magellan Midstream Partners LP (MMP):石油・ガス:M&Aディール及び事業提携情報
    Summary Magellan Midstream Partners LP (Magellan Midstream) is a midstream energy company. It transports, stores, and distributes refined petroleum products and crude oil. The company handles various petroleum products such as gasoline, diesel fuel, and crude oil. Magellan Midstream owns and operate …
  • The Kansai Electric Power Company Inc (9503)-エネルギー分野:企業M&A・提携分析
    Summary The Kansai Electric Power Company Inc (KEPCo) is an integrated power utility. The company produces and supplies electricity; and procures and sells natural gas. It generates electricity from natural gas, oil, nuclear, coal, hydro, wind, and solar sources. Through long, medium, and short term …
  • ABB Ltd (ABBN)-エネルギー分野:企業M&A・提携分析
    Summary ABB Ltd. (ABB) is a provider of power and automation technologies. The company provides solutions for secure, energy-efficient generation, transmission and distribution of electricity and for increasing productivity in industrial, commercial and utility operations. ABB’s product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆